CB
ABBV icon

Chemical Bank’s AbbVie ABBV Stock Holding History

Chemical Bank’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$8.7M Sell
119,637
-1,189
-1% -$93.5K 0.99% 25
2019
Q1 		$9.74M Sell
120,826
-3,600
-3% -$295K 1.1% 19
2018
Q4 		$11.5M Sell
124,426
-3,653
-3% -$321K 1.42% 6
2018
Q3 		$12.1M Sell
128,079
-3,062
-2% -$290K 1.25% 10
2018
Q2 		$12.2M Buy
131,141
+397
+0.3% +$38.8K 1.31% 6
2018
Q1 		$12.4M Buy
130,744
+1,367
+1% +$150K 1.35% 6
2017
Q4 		$12.5M Sell
129,377
-4,099
-3% -$386K 1.35% 7
2017
Q3 		$11.9M Sell
133,476
-14,925
-10% -$1.14M 1.32% 7
2017
Q2 		$10.8M Buy
148,401
+69
+0% +$4.64K 1.18% 9
2017
Q1 		$9.66M Sell
148,332
-940
-0.6% -$59.1K 1.07% 18
2016
Q4 		$9.35M Buy
149,272
+23,745
+19% +$1.45M 1.07% 17
2016
Q3 		$7.92M Sell
125,527
-1,995
-2% -$129K 1.07% 17
2016
Q2 		$7.89M Buy
127,522
+5,095
+4% +$310K 1.09% 17
2016
Q1 		$6.99M Buy
122,427
+854
+0.7% +$47.6K 0.98% 19
2015
Q4 		$7.2M Sell
121,573
-6,476
-5% -$373K 1% 18
2015
Q3 		$6.97M Sell
128,049
-3,337
-3% -$217K 1% 17
2015
Q2 		$8.83M Buy
131,386
+3,691
+3% +$241K 1.17% 13
2015
Q1 		$7.47M Buy
127,695
+11,068
+9% +$669K 0.98% 17
2014
Q4 		$7.63M Buy
116,627
+14,794
+15% +$933K 0.99% 18
2014
Q3 		$5.88M Sell
101,833
-803
-0.8% -$44.6K 1.02% 13
2014
Q2 		$5.79M Buy
102,636
+570
+0.6% +$29.9K 0.98% 14
2014
Q1 		$5.25M Sell
102,066
-540
-0.5% -$27.3K 0.94% 15
2013
Q4 		$5.42M Buy
102,606
+550
+0.5% +$27K 0.96% 17
2013
Q3 		$4.57M Buy
102,056
+2,490
+3% +$110K 0.88% 19
2013
Q2 		$4.12M Buy
+99,566
New +$4.35M 0.81% 26

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Chemical Bank's ABBV Position: Q2 2019 in Review

Chemical Bank reduced its AbbVie (ABBV) stake by 0.98% in Q2 2019, selling an estimated $93.5K and leaving 119,637 shares worth $8.7M. The position accounts for 0.99% of the portfolio, ranked #25.

Chemical Bank first reported a position in ABBV in Q2 2013 and has held it in 25 quarters since. The position peaked at $12.5M in Q4 2017. 2,020 funds tracked by Wall St. Rank hold ABBV as of Q2 2019.

  • Chemical Bank held 119,637 shares of AbbVie worth $8.7M as of Q2 2019.
  • Chemical Bank sold 1,189 AbbVie shares in Q2 2019, an estimated $93.5K.
  • AbbVie made up 0.99% of Chemical Bank's portfolio in Q2 2019, its #25 holding.
  • Chemical Bank first reported a position in AbbVie in Q2 2013 and has held it in 25 quarters since.
  • Chemical Bank's AbbVie position peaked at $12.5M in Q4 2017.
  • 2,020 funds tracked by Wall St. Rank held AbbVie as of Q2 2019.

Based on Chemical Bank's 13F filing for Q2 2019, filed 25 Jul 2019.